Oct 02, 2019 / 07:00PM GMT
Craig Bijou - Cantor Fitzgerald - Analyst
Hello, my name is Craig Bijou. I am the medical device analyst here at Cantor Fitzgerald. Happy to have Cerus Corporation here: Kevin Green, CFO; Tim Lee, IR. Thanks, guys, for joining us.
I want to start -- there might be some in the audience that may not be as familiar with your story, a very interesting story. So I wanted to see if you can provide maybe a high-level overview of what you guys do and what you are working on.
Kevin Green - Cerus Corporation - VP Finance and CFO
Sure. So we inactivate -- we have a product that inactivates pathogens and blood components for transfusion. So we are a disruptive technology, if you will, to testing for viral load or bacterial load. And we focus on commercially today and around the world in the platelet and plasma components and we've got pipeline opportunities for red cells.
The way that the system works is we have a small molecule that we add to a blood donation and it intercalates with nucleic acid strands. And when it is exposed to ultraviolet A light, in
Cerus Corp at Cantor Fitzgerald Global Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers